• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Endocrinol Invest . Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece i

tetano

Editor, Senior Moderator
J Endocrinol Invest


. 2021 Nov 18.
doi: 10.1007/s40618-021-01700-7. Online ahead of print.
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle


W Vena[SUP] #[/SUP][SUP] 1 [/SUP], A Pizzocaro[SUP] #[/SUP][SUP] 1 [/SUP], G Maida[SUP] 1 [/SUP], M Amer[SUP] 1 [/SUP], A Voza[SUP] 2 [/SUP], A Di Pasquale[SUP] 3 [/SUP], F Reggiani[SUP] 4 [/SUP], M Ciccarelli[SUP] 3 [/SUP], C Fedeli[SUP] 2 [/SUP], D Santi[SUP] 5 [/SUP], E Lavezzi[SUP] 1 6 [/SUP], A G Lania[SUP] 7 8 [/SUP], G Mazziotti[SUP] 1 6 [/SUP], Humanitas COVID19 Task Force



Affiliations

Abstract

Purpose: Hypogonadism was described in high number of male subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In this study, we investigated whether low testosterone (T) values may influence the clinical presentation and outcome of SARS-CoV-2-related pneumonia in a large population of adult males with coronavirus disease 19 (COVID-19).
Methods: Two hundred twenty one adult males hospitalized for COVID-19 at the IRCCS Humanitas Research Hospital, Rozzano-Milan (Italy) were consecutively evaluated for arterial partial pressure oxygen (PaO[SUB]2[/SUB])/fraction of inspired oxygen (FiO[SUB]2[/SUB]) ratio, serum T and inflammatory parameters at study entry, need of ventilation during hospital stay and in-hospital mortality.
Results: Subjects low T values (< 8 nmol/L; 176 cases) were significantly older (P = 0.001) and had higher serum interleukin-6 (P = 0.001), C-reactive protein (P < 0.001), lactate dehydrogenase (P < 0.001), ferritin (P = 0.012), lower P/F ratio (P = 0.001), increased prevalence of low T3 syndrome (P = 0.041), acute respiratory insufficiency (P < 0.001), more frequently need of ventilation (P < 0.001) and higher mortality rate (P = 0.009) compared to subjects with higher T values. In the multivariable regression analyses, T values maintained significant associations with acute respiratory insufficiency (odds ratio [OR] 0.85, 95% confidence interval [CI] 0.79-0.94; P < 0.001 and in-hospital mortality (OR 0.80, 95% CI 0.69-0.95; P = 0.009), independently of age, comorbidities, thyroid function and inflammation.
Conclusion: Low T levels values are associated with unfavorable outcome of COVID-19. Prospective studies are needed to evaluate the long-term outcomes of hypogonadism related to COVID-19 and the clinical impact of T replacement during and after acute illness.

Keywords: COVID-19; Hypogonadism; Mortality; Pneumonia; SARS-CoV-2 infection; Testosterone.
 
Back
Top Bottom